FDA Approved: FAMOTIDINE — Supplemental Application (Sagent Pharmaceuticals)

View source ↗

Summary

FDA approved a supplemental application for famotidine from Sagent Pharmaceuticals, confirming the generic product under ANDA075651.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Duodenal Ulcer
• Erosive Esophagitis
• Gastric Ulcer
• Gastroesophageal Reflux Disease

Drugs mentioned

• Famotidine (famotidine)

Snippet

SUPPL AP for FAMOTIDINE (FAMOTIDINE)